The Enterprise Value as of June 2026 (TTM) for Aerovate Therapeutics, Inc. (AVTE) is 452.27M

According to Aerovate Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 452.27M. This represents a change of -14.59% compared to the average of 529.51M of the last 4 quarters.

Aerovate Therapeutics, Inc. (AVTE) Historical Enterprise Value (quarterly & annually)

How has AVTE Enterprise Value performed in the past?

The mean historical Enterprise Value of Aerovate Therapeutics, Inc. over the last ten years is 415.71M. The current 452.27M Enterprise Value has changed 10.78% with respect to the historical average. Over the past ten years (40 quarters), AVTE's Enterprise Value was at its highest in in the December 2025 quarter at 1.00B. The Enterprise Value was at its lowest in in the June 2024 quarter at 18.50M.

Aerovate Therapeutics, Inc. (AVTE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aerovate Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aerovate Therapeutics, Inc. (AVTE) Average Enterprise Value

How has AVTE Enterprise Value performed in the past?

The current Enterprise Value of Aerovate Therapeutics, Inc. (AVTE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aerovate Therapeutics, Inc. (AVTE) Enterprise Value vs. Peers

How is AVTE’s Enterprise Value compared to its peers?

Aerovate Therapeutics, Inc.’s Enterprise Value is greater than IGM Biosciences, Inc. (46.85M), greater than Quince Therapeutics, Inc. (-12743995.00), greater than Landos Biopharma, Inc. (34.13M), greater than Berkeley Lights, Inc. (42.64M), greater than enVVeno Medical Corporation (-1820058.00), greater than Surface Oncology, Inc. (70.21M), greater than Insight Molecular Diagnostics Inc. (117.66M), greater than Reneo Pharmaceuticals, Inc. (-130856584.00), greater than Miromatrix Medical Inc. (91.30M), greater than Achilles Therapeutics plc (-66096000.00),

Build a custom stock screener for Aerovate Therapeutics, Inc. (AVTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aerovate Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aerovate Therapeutics, Inc. (AVTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aerovate Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.